ATE123064T1 - Methoden und zusammensetzungen zur behandlung von bösartigen entartungen, die in zusammenhang mit einer proteinkinase stehen. - Google Patents
Methoden und zusammensetzungen zur behandlung von bösartigen entartungen, die in zusammenhang mit einer proteinkinase stehen.Info
- Publication number
- ATE123064T1 ATE123064T1 AT91906924T AT91906924T ATE123064T1 AT E123064 T1 ATE123064 T1 AT E123064T1 AT 91906924 T AT91906924 T AT 91906924T AT 91906924 T AT91906924 T AT 91906924T AT E123064 T1 ATE123064 T1 AT E123064T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- protein kinase
- treating malignant
- malignancies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49403690A | 1990-03-14 | 1990-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE123064T1 true ATE123064T1 (de) | 1995-06-15 |
Family
ID=23962758
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94109172T ATE170561T1 (de) | 1990-03-14 | 1991-03-14 | Methode und zusammensetzungen zur behandlung von bösartigen entartungen, die in zusammenhang mit einer proteinkinase stehen |
AT91906924T ATE123064T1 (de) | 1990-03-14 | 1991-03-14 | Methoden und zusammensetzungen zur behandlung von bösartigen entartungen, die in zusammenhang mit einer proteinkinase stehen. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94109172T ATE170561T1 (de) | 1990-03-14 | 1991-03-14 | Methode und zusammensetzungen zur behandlung von bösartigen entartungen, die in zusammenhang mit einer proteinkinase stehen |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP0520029B1 (de) |
JP (1) | JPH05505527A (de) |
AT (2) | ATE170561T1 (de) |
CA (1) | CA2078010A1 (de) |
DE (2) | DE69130117D1 (de) |
DK (1) | DK0520029T3 (de) |
ES (1) | ES2073165T3 (de) |
GR (1) | GR3017164T3 (de) |
WO (1) | WO1991013989A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE911115A1 (en) * | 1990-04-10 | 1991-10-23 | Canji Inc | Gene therapy for cell proliferative diseases |
US5536636A (en) * | 1991-06-26 | 1996-07-16 | Beth Israel Hospital | Methods for identifying a tyrosine phosphatase abnormality associated with neoplastic disease |
GB9214754D0 (en) * | 1992-07-10 | 1992-08-19 | Univ Singapore | Tumour treatment |
MX9304769A (es) * | 1992-08-05 | 1994-05-31 | Max Planck Gesellschaft | Subfamilia ptp-d de fosfatasas de la proteina tirosina. |
AU6688696A (en) * | 1995-08-10 | 1997-03-05 | Incyte Pharmaceuticals, Inc. | Non-receptor type human protein tyrosine phosphatase |
US6238902B1 (en) | 1996-03-22 | 2001-05-29 | Genentech, Inc. | Protein tyrosine phosphatases |
AU719909B2 (en) * | 1996-03-22 | 2000-05-18 | Genentech Inc. | Protein tyrosine phosphatases of hematopoietic cells |
US6248327B1 (en) | 1998-09-11 | 2001-06-19 | Vanderbilt University | Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
US7176289B1 (en) | 1998-09-11 | 2007-02-13 | Vanderbilt University | Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
US6485974B1 (en) * | 2001-05-18 | 2002-11-26 | Isis Pharmaceuticals, Inc. | Antisense modulation of PTPN2 expression |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4710469A (en) * | 1986-05-02 | 1987-12-01 | Merck & Co., Inc. | Novel phosphotyrosyl protein phosphatase |
-
1991
- 1991-03-14 WO PCT/US1991/001748 patent/WO1991013989A1/en active IP Right Grant
- 1991-03-14 DK DK91906924.5T patent/DK0520029T3/da active
- 1991-03-14 JP JP91507242A patent/JPH05505527A/ja active Pending
- 1991-03-14 DE DE69130117T patent/DE69130117D1/de not_active Expired - Lifetime
- 1991-03-14 AT AT94109172T patent/ATE170561T1/de not_active IP Right Cessation
- 1991-03-14 ES ES91906924T patent/ES2073165T3/es not_active Expired - Lifetime
- 1991-03-14 DE DE69110034T patent/DE69110034T2/de not_active Expired - Fee Related
- 1991-03-14 EP EP91906924A patent/EP0520029B1/de not_active Expired - Lifetime
- 1991-03-14 CA CA002078010A patent/CA2078010A1/en not_active Abandoned
- 1991-03-14 AT AT91906924T patent/ATE123064T1/de not_active IP Right Cessation
- 1991-03-14 EP EP94109172A patent/EP0627489B1/de not_active Expired - Lifetime
-
1995
- 1995-08-23 GR GR950402274T patent/GR3017164T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0520029T3 (da) | 1995-10-16 |
EP0627489B1 (de) | 1998-09-02 |
JPH05505527A (ja) | 1993-08-19 |
ES2073165T3 (es) | 1995-08-01 |
DE69130117D1 (de) | 1998-10-08 |
GR3017164T3 (en) | 1995-11-30 |
DE69110034D1 (de) | 1995-06-29 |
EP0627489A1 (de) | 1994-12-07 |
WO1991013989A1 (en) | 1991-09-19 |
EP0520029B1 (de) | 1995-05-24 |
ATE170561T1 (de) | 1998-09-15 |
EP0520029A1 (de) | 1992-12-30 |
CA2078010A1 (en) | 1992-09-15 |
DE69110034T2 (de) | 1995-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2170366T3 (es) | Secuencia de adn aislada del gen brca1 y su utilizacion en terapia antitumoral. | |
DE69131255T2 (de) | Immunreaktivität gegenüber exprimierten aktivierten Oncogenen zur Diagnose und Behandlung von bösartigen Geschwülsten | |
ATE167524T1 (de) | Verfahren zum nachweis, identifizieren und quantifizieren von organismen und viren | |
ATE123064T1 (de) | Methoden und zusammensetzungen zur behandlung von bösartigen entartungen, die in zusammenhang mit einer proteinkinase stehen. | |
ATE380195T1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren | |
DE69126710T2 (de) | Oligonukleotide zur modulation der effekte von cytomegalovirusinfektionen | |
DE69635848D1 (de) | Verfahren zum Nachweis von Ki-ras Mutationen | |
DE3869485D1 (de) | Behandlung von autophoretisch abgeschiedenen ueberzuegen zur glanzverbesserung. | |
ATE305051T1 (de) | Genetische marker und methoden zum detektion von escherichia coli serotype-0157:h7 | |
DE69021742D1 (de) | Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck. | |
ATE429517T1 (de) | Vervielfältigung und nachweis von ebv barf1 zur diagnose von nasopharyngealen karzinom | |
ATE224453T1 (de) | Verwendung eines spezifischen markers zur detektion von salmonellen mit pcr | |
SE7806087L (sv) | Forfarande for rening av nukleotidsekvenser lempliga som syntetiseringsmall i bakterier, mikroorganism innefattande dylik nukleotidsekvens samt rekombinant dna-overforingsvektor innefattande dylik nukleotid | |
DE69131691T2 (de) | Genomische genkartierungsmethode durch direkten nachweis von haplotypen mittels intronsequenzanalyse | |
DE3686688T2 (de) | Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten. | |
DE68910036T2 (de) | Luciferase-Gen und neue rekombinante DNA sowie Verfahren zur Herstellung von Luciferase. | |
DE59106112D1 (de) | Verfahren zur Inaktivierung der biologischen Aktivität von DNA. | |
DE59709012D1 (de) | Verwendung von primern für universelle fingerprint-analysen | |
EA199900339A1 (ru) | Ген роста человека и область гена, ответственная за низкий рост | |
DE59902472D1 (de) | Zusammensetzung zur induktion einer tumorspezifischen immunantwort, verfahren zu deren herstellung sowie verwendung der zusammensetzung zur behandlung von neoplasien | |
CA2347371A1 (en) | HEMATOPOIETIC REGULATION FACTORS AND METHODS OF USE | |
DE69002838D1 (de) | Verfahren zur Verbesserung für die Naturtrocknung von biologischen Produkten und dadurch behandelte Produkte. | |
DE60131320D1 (de) | Eine Nukleinsäure, die in menschlichen Tumorzellen aufreguliert wird, ein von dieser kodiertes Protein und ein Verfahren zur Tumordiagnose | |
Sinegre et al. | Identification of Spore-Forming Sulfite-Reducing Bacteria Determined in Water. | |
ATE39496T1 (de) | Verfahren zur identifizierung und charakterisierung von organismen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |